Boston Scientific, Medinol Coronary Stent IDE Approvals Precede Legal Duel
This article was originally published in The Gray Sheet
Executive Summary
Medinol's April 2001 lawsuit alleging Boston Scientific's development of the Express stent constitutes a breach of contract will likely be heard in New York federal court by late summer